VEGF-C

CAT:
209-101-M90
Size:
100 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
VEGF-C - image 1

VEGF-C

  • Description:

    VEGF-C, also known as Vascular Endothelial Growth Factor Related Protein (VRP), is a recently discovered VEGF growth factor family member that is most closely related to VEGF-D. The human VEGF-C cDNA encodes a pre-pro-protein of 416 amino acids residues. It is almost identical to the mouse VEGF-C protein. Similar to VEGF-D, VEGF-C has a VEGF homology domain spanning the middle third of the precursor molecule and long N- and C-terminal extensions. In adults, VEGF-C is highly expressed in heart, placenta, ovary and small intestine. Recombinant human VEGF-C, lacking the N- and C-terminal extensions and containing only the middle VEGF homology domain, forms primarily non-covalently linked dimers. This protein is a ligand for both VEGFR-2/KDR and VEGFR-3/FLT-4. Since VEGFR-3 is strongly expressed in lymphatic endothelial cells, it has been postulated that VEGF-C is involved in the regulation of the growth and/or differentiation of lymphatic endothelium. Although recombinant human VEGF-C is also a mitogen for vascular endothelial cells, it is much less potent than VEGF-A. The recombinant human VEGF-C contains 115 amino acids residues and was fused to a His-tag (6x His) at the C-terminal end. As a result of glycosylation VEGF-C migrates as an 18-24 kDa protein in SDS-PAGE under reducing conditions.
  • Synonyms:

    Vascular endothelial growth factor C; VEGFC; VRP; Flt4-L
  • NCBI Gene ID:

    7424
  • UniProt:

    P49767
  • Accession Number:

    NP_005420.1
  • Accession Number mRNA:

    NM_005429.2
  • Chromosomal Location:

    11q13
  • Reactivity:

    Anti-Human
  • Cross Reactivity:

    Human, rat
  • Target Antigen:

    Recombinant human VEGF-C (RT# 300-079)
  • Clone:

    (#9E7)
  • Applications:

    WB, IHC (F)
  • Purification Method:

    Protein G affinity chromatography
  • Assay Protocol:

    Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/ml.
  • Bioactivity:

    Western Blot: Use at 1-5 µg/ml; IHC: Use at 2-10 µg/ml
  • Form:

    Lyophilized
  • Buffer:

    PBS
  • Reconstitution:

    Water
  • Storage Conditions:

    The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.
  • Notes:

    This antibody detects human and rat VEGF-C in Western blots. No cross-reactivity is shown with VEGF-A.
  • Host or Source:

    Mouse
  • Isotype:

    IgG2a